Combined with our previous observation that serum RANKL level in MM patients correlated positively with that of soluble BDNF, these results suggest that BDNF may be an important contributing factor to the RANKL pool in bone, thus promoting osteoclast formation and bone destruction in MM. Here, BDNF is linked to Miyoshi myopathy.